Navigation Links
The Chiesi Group Lands in the United States
Date:5/7/2009

ris and Rockville (USA), in 2008 the company added Chippenham (UK) which has set itself the objective of innovating in the field of pressurised aerosols.

There are 3,243 people working for Chiesi, of whom more than 300 are employed in research. Last year, the Group's work force grew by 10%, with new hires mainly in Italy, Spain, Eastern Europe, Russia, Greece and in the new subsidiaries in the Netherlands, Turkey and China.

Cornerstone Profile

Cornerstone Therapeutics Inc. (NASDAQ CM: CRTX), headquartered in Cary, N.C., is a pharmaceutical company focusing on the acquisition, development and marketing of prescription drugs for the respiratory therapeutics area. The company, which in 2008 had revenues of 64.9 million dollars, a 131% increase over 2007, is currently promoting non-proprietary drugs in the United States; it has its own marketing network selling to specialists in respiratory illnesses and the main pharmacies. In addition, Cornerstone, which in 2008 invested about 3.8 million dollars in R&D, has a pipeline of molecules in the advanced clinical phase; thanks to these, it plans to submit some new products to the registration procedure in the next three years. Cornerstone's marketing strategy consists of increasing its market share for those products it is marketing through its own marketing and promotional skills, of acquiring new pharmaceutical products and of maximising the value of the products currently marketed, as soon as they are acquired, or of the drug candidates under development.


'/>"/>
SOURCE Chiesi Farmaceutici S.p.A.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Simcere Pharmaceutical Group to Announce 2009 First Quarter Earnings on Monday, May 18, 2009
2. DuPont Statement on Obama Administration Biofuels Interagency Working Group
3. The Arcas Group Appoints Executive Vice President
4. Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury
5. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
6. Encorium Group Signs Approximately $2.0 Million of New Business Contracts
7. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
8. Mach One BioPharm Process Operating Group Receives Contract From American Beef Processors
9. Bio-Matrix Scientific Group, Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc.
10. Disabled and other vulnerable groups more susceptible to terrorism fears
11. ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... ALBANY, N.Y. , June 18, 2013 /PRNewswire/ ... that its Burlington, Mass. , ... U.S. Drug Enforcement Administration (DEA) registration to handle ... represents the DEA,s acknowledgement of Burlington,s ... inventory control and documentation. (Logo: ...
(Date:6/18/2013)...  Techne Corporation (NASDAQ: TECH ) ... acquire 100% ownership of Bionostics Holdings Limited and ... a global leader in the development, manufacture and ... operation of in vitro diagnostic (IVD) ... glucose and blood gas testing.  Biosnostics has strategic ...
(Date:6/18/2013)... Research and Markets ... of the "Injectable Drug Delivery Market ... [Disposables & Reusable, Fillable & Prefilled, Pen, ... [Diabetes & Oncology] - Global Forecasts to ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,The ...
(Date:6/18/2013)... June 18, 2013 ... ) has announced the addition of ... & Stable Isotopes Market [SPECT/PET Radioisotopes ... Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, ... report to their offering. ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3
... Enerkem one step closer to becoming the, ... use waste, feedstock,MONTREAL, Jan. 12 /PRNewswire/ ... technology company, announced today that its first commercial-scale plant ... with the production of its clean conditioned synthesis gas. ...
... Biosystems,Inc. (OTC Bulletin Board: WGBS), a leading ... and stem cell research systems, today,announced that ... the company,s SmartChip(TM) Real-Time PCR System in ... testing program. Initial tests,conducted at the ...
... Board of Directors of SemBioSys Genetics Inc. (TSX:SBS), ... plants, today announced that current President and CEO ... position of President and CEO of Botaneco Specialty ... the corporation,s Chief Financial Officer, has been named ...
Cached Biology Technology:Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase 2Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase 3WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 2WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 3WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 4WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 5SemBioSys announces senior management changes 2SemBioSys announces senior management changes 3SemBioSys announces senior management changes 4
(Date:6/17/2013)... understand the concept of improving original foundations with more ... the University of Pittsburgh,s Kenneth P. Dietrich School of ... that could make drug delivery, gas storage, and gas ... findings were reported in the latest issue of the ... JACS ). , The recent work builds upon Pitt ...
(Date:6/17/2013)... A Kansas State University research associate has received a ... ways to prevent the spread of malaria. , Bart ... Institutes of Health,s National Research Service Award Individual Postdoctoral ... the seventh Kansas State University researcher to receive the ... currently hold such an award. , Bryant, a university ...
(Date:6/17/2013)... Fracking, the controversial method of mining shale gas, is ... the Appalachian Basin. New research in the Annals ... the threat posed to biodiversity including pollution from toxic ... changes to wetlands. , "Shale gas has engendered a ... on human health, but effects on biological diversity and ...
Breaking Biology News(10 mins):'Chemical architects' build materials with potential applications in drug delivery and gas storage 2NIH fellowship helps researcher fight malaria, understand mosquito immunity 2
... trial launched in Pittsburgh, Pennsylvania today, with sites preparing ... Scientists will test the rectal safety and acceptability of ... has shown promise for preventing HIV through vaginal intercourse. ... gel could be further evaluated to determine if it ...
... its primitive structure, the North American comb jellyfish can ... submarine, making it a successful predator. Researchers, including one ... to show how the jellyfish makes itself hydrodynamically ,invisible,. ... has long been known to consume vast quantities ...
... 2010 A research team at Ben-Gurion University of the ... detected a genetic mutation resulting in a progressive disease of ... research was just published in the American Journal of ... Ohad Birk of the National Institute for Biotechnology in the ...
Cached Biology News:International Rectal Microbicide Advocates cheers launch of world's third rectal microbicide trial 2International Rectal Microbicide Advocates cheers launch of world's third rectal microbicide trial 3Voracious comb jellyfish 'invisible' to prey 2Genetic defect found to cause severe epilepsy and mental retardation 2
... cultured in DMEM and harvested at the log ... the antigens in their native forms, cells were ... on a 12-well (5 mm) adhesive coated slide, ... cellular attachment and to minimize background staining. ...
... CopyControl™ vector can be induced prior to ... provide the stability of single-copy BACs with ... other cloning vectors. The kits provide the ... insert size screening system) necessary to create ...
... / 3T3 cells were cultured in DMEM with ... phase of growth. In order to keep ... fixed in acetone-methanol. The cells are arrayed ... with each wells surface specifically treated to enhance ...
... The CopyControl™ vector can be induced prior ... vectors provide the stability of single-copy BACs ... or other cloning vectors. The kits provide ... reagents, insert size screening system) necessary to ...
Biology Products: